TCG Crossover Management’s RayzeBio RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-869,908
Closed -$54.1M – 36
2023
Q4
$54.1M Hold
869,908
– – 6% 5
2023
Q3
$19.3M Buy
+869,908
New +$18.3M 2.84% 17

TCG Crossover Management's RYZB Position: Q1 2024 in Review

TCG Crossover Management sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 869,908 shares — an estimated $54.1M sold.

TCG Crossover Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $54.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • TCG Crossover Management reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
  • TCG Crossover Management sold 869,908 RayzeBio shares in Q1 2024, an estimated $54.1M.
  • TCG Crossover Management first reported a position in RayzeBio in Q3 2023 and held it in 2 quarters.
  • TCG Crossover Management's RayzeBio position peaked at $54.1M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.

Based on TCG Crossover Management's 13F filing for Q1 2024, filed 15 May 2024.